Optimizing the Use of Topical Agents in Psoriasis

被引:0
|
作者
Stein, Linda F. [1 ]
机构
[1] Henry Ford Hlth Syst, Dermatol Res, Detroit, MI USA
关键词
Corticosteroids; JAK; Janus kinase inhibitors; phosphodiesterase-4; inhibitors; pimecrolimus; psoriasis treatment; skin atrophy; tacrolimus; topical; vitamin D; ATOPIC-DERMATITIS; PLAQUE PSORIASIS; PROPIONATE CREAM; CORTICOSTEROIDS; 0.1-PERCENT; OINTMENT;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The vast majority of patients with psoriasis have localized disease that is manageable by topical therapy alone, and patients with more severe disease still require topical treatment for plaques that persist despite effective systemic treatment or phototherapy. Nevertheless, little attention today is paid to topical therapy, including new topical treatments. This article briefly addresses key issues that can adversely affect the use of and compliance with currently available topical treatments, as well as new and emerging topical agents for psoriasis. (C) 2014 published by Frontline Medical Communications
引用
收藏
页码:S24 / S26
页数:3
相关论文
共 50 条
  • [21] Use of topical therapies for pediatric psoriasis: A systematic review
    Kravvas, Georgios
    Gholam, Karolina
    PEDIATRIC DERMATOLOGY, 2018, 35 (03) : 296 - 302
  • [22] Predictors of Topical Use in Psoriasis Patients in the REFINE Study
    Gooderham, Melinda J.
    Poulin-Costello, Melanie
    Shelton, Jennifer
    Bayan, Nabil
    Papp, Kim A.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2016, 20 (02) : 106 - 112
  • [23] Predictors of topical use in psoriasis patients in the REFINE study
    Gooderham, Melinda
    Poulin-Costello, Melanie
    Shelton, Jennifer
    Bayan, Nabil
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB244 - AB244
  • [24] Use of superpotent topical corticosteroids for psoriasis patients in the US
    Pearce, D
    Fleischer, A
    Balkrishnan, R
    Feldman, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P150 - P150
  • [25] Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis
    Gomes, Graziela S.
    Frank, Luiza A.
    V. Contri, Renata
    Longhi, Maria S.
    Pohlmann, Adriana R.
    Guterres, Silvia S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 631
  • [26] Efficacy of topical agents under hydrophilic occlusion versus unoccluded in psoriasis
    Koo, John
    Colaco, Shanthi M.
    Sivanesan, Priya
    Malick, Farah
    Letsinger, Julie A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1814 - 1814
  • [27] Optimizing the use of topical retinoids in Asian acne patients
    See, Jo-Ann
    Goh, Chee Leok
    Hayashi, Nobukazu
    Suh, Dae Hun
    Casintahan, Flordeliz Abad
    JOURNAL OF DERMATOLOGY, 2018, 45 (05): : 522 - 528
  • [28] Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents
    Marques, Emanuel
    Paluch, Zoltan
    Bohac, Petr
    Slanar, Ondrej
    Belacek, Jaromir
    Hercogova, Jana
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1435 - 1448
  • [29] A VEHICLE FOR THE TOPICAL USE OF CERTAIN THERAPEUTIC AGENTS
    PRIGOT, A
    WRIGHT, LT
    QUASH, ET
    ANTIBIOTICS AND CHEMOTHERAPY, 1953, 3 (04) : 418 - 420
  • [30] USE OF ORAL AND TOPICAL AGENTS FOR ACNE IN PREGNANCY
    ROTHMAN, KF
    POCHI, PE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (03) : 431 - 442